Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodies
Tomohiro Tanaka, Tatsuya Yoshida, Ken Masuda, Yuki Takeyasu, Yuki Shinno, Yuji Matsumoto, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe
Topics & Concepts
MedicineInternal medicineNivolumabHazard ratioLung cancerConfidence intervalCancerPembrolizumabGastroenterologyOncologyImmunotherapyInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis